Please login to the form below

Eklira

This page shows the latest Eklira news and features for those working in and with pharma, biotech and healthcare.

AZ adds to respiratory portfolio with Actavis drugs

It follows a similar deal agreed in July last year for AZ to buy the global respiratory portfolio of Almirall for $2bn, including the approved Eklira (aclidinium) for COPD and several

Latest news

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio

Almirall's franchise includes Eklira (aclidinium), LAS40464 (a combination of aclidinium with formoterol, which has been filed in Europe), LAS100977 (abediterol), a once-daily phase II long-acting beta2-agonist (LABA),
Almirall expands in US via $400m deal to buy Aqua

under 22m on the back of high roll-out costs for new products such as Sativex (nabiximols) for spasticity in multiple sclerosis (MS) and chronic obstructive pulmonary disorder (COPD) treatment Eklira
IQWiG knocks back Almirall's Eklira

IQWiG knocks back Almirall's Eklira. Decides added benefit of COPD drug is not proven. ... A long-acting bronchodilator, Eklira is licensed to treat adults with chronic-obstructive pulmonary disease (COPD) and works by widening their narrowed airways.
Forest Labs launches COPD drug Tudorza in US

sold as Eklira and Bretaris Genuair.
Almirall's IBS drug Constella backed by CHMP

COPD) treatment Eklira/Tudorza (aclidinium bromide).

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

Deal Watch table for November 2014

Eklira and Duaklir. Business unit acquisition. 3, 075. Pfizer / Merck KGaA.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Medical Writer - Creative and Scientific Projects: DOE

Senior Medical Writer: Salary is DOE

Associate Scientific Director: Salary TBC

Account Manager: Negotiable

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Medical Writers Required - Hertfordshire: Competitive

Senior Account Manager – Healthcare Advertising: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Market Access Consultant - Greater Manchester: Negotiable

Systematic Review Lead- London: Negotiable

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Graduate Scientific Editor: DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Healthcare PR Senior Account Manager: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Subscribe to our email news alerts

PMHub

Add my company

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....